RM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| ONE SHOT - single shot radiotherapy for localized prostate cancer : 18-month results of a single arm, multicenter phase I/II trial | Radiotherapy and oncology | 2024 | 91 | 49 | |||
| Single-fraction prostate stereotactic body radiotherapy : Dose reconstruction with electromagnetic intrafraction motion tracking | Radiotherapy and oncology | 2021 | 1 | 2 | |||
| Electromagnetic Transponder Localization and Real-Time Tracking for Prostate Cancer Radiation Therapy: Clinical Impact of Metallic Hip Prostheses | Practical Radiation Oncology | 2020 | 283 | 0 | |||
| Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results | Cancer Medicine | 2020 | 300 | 477 | |||
| Atlas Sampling for Prone Breast Automatic Segmentation of Organs at Risk: The Importance of Patients' Body Mass Index and Breast Cup Size for an Optimized Contouring of the Heart and the Coronary Vessels | Technology in Cancer Research and Treatment | 2020 | 254 | 155 | |||
| Resources-stratified guidelines for classical hodgkin lymphoma | International Journal of Environmental Research and Public Health | 2020 | 412 | 379 | |||
| Prostate cancer nonascitic peritoneal carcinomatosis after robot-assisted laparoscopic radical prostatectomy: 3 case reports and review of the literature | Urology | 2020 | 321 | 0 | |||
| Image-guided total-body irradiation with a movable electronic portal imaging device for bone marrow transplant conditioning | Zeitschrift für Medizinische Physik | 2019 | 310 | 0 | |||
| Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy | European Urology | 2019 | 348 | 0 | |||
| Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI | Medical Oncology | 2019 | 356 | 0 | |||
| Mild hyperthermia by MR-guided focused ultrasound in an ex vivo model of osteolytic bone tumour: optimization of the spatio-temporal control of the delivered temperature | Journal of Translational Medicine | 2019 | 342 | 183 | |||
| Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial | Radiotherapy and Oncology | 2019 | 252 | 0 | |||
| Neck management in head and neck squamous cell carcinomas: where do we stand? | Medical Oncology | 2019 | 253 | 1 | |||
| Oligometastatic prostate cancer: The game is afoot | Cancer Treatment Reviews | 2019 | 283 | 0 | |||
| Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter? | Journal of Cancer Research and Clinical Oncology | 2019 | 259 | 0 | |||
| Dose optimization and endorectal balloon for internal pudendal arteries sparing in prostate SBRT | Physica Medica | 2019 | 255 | 0 | |||
| De la construction du bunker à la prise en charge du patient : contrôles qualité des techniques modernes de radiothérapie | Cancer Radiothérapie | 2019 | 373 | 0 | |||
| Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon? | Radiation Oncology | 2018 | 448 | 243 | |||
| Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy | Medical Oncology | 2018 | 435 | 551 | |||
| Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far? | Cancer Treatment Reviews | 2018 | 467 | 0 | |||
| Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients | Journal of Cancer Research and Clinical Oncology | 2018 | 442 | 457 | |||
| Oligorecurrent Nodal Prostate Cancer: Long-term Results of an Elective Nodal Irradiation Approach | American Journal of Clinical Oncology | 2018 | 451 | 0 | |||
| Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042) | Radiotherapy and Oncology | 2018 | 490 | 1,971 | |||
| First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9 | EJNMMI Research | 2018 | 387 | 206 | |||
| La santé sexuelle après radiothérapie | Revue médicale suisse | 2018 | 610 | 343 | |||
| Improving 3D-printing of megavoltage X-rays radiotherapy bolus with surface-scanner | Radiation Oncology | 2018 | 346 | 213 | |||
| ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial | Radiation Oncology | 2018 | 453 | 278 | |||
| The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An 18F-MISO PET-MRI Study | International Journal of Radiation Oncology, Biology, Physics | 2018 | 491 | 0 | |||
| Long-term Results of a Comparative PET/CT and PET/MRI Study of 11 C-Acetate and 18 F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer | Clinical nuclear medicine | 2017 | 605 | 2 | |||
| Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial | JAMA Oncology | 2017 | 540 | 0 | |||
| Results of Dose-adapted Salvage Radiotherapy After Radical Prostatectomy Based on an Endorectal MRI Target Definition Model | American journal of clinical oncology | 2017 | 518 | 0 | |||
| Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule | Clinical Oncology | 2017 | 491 | 529 | |||
| The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy | Acta Oncologica | 2017 | 607 | 328 | |||
| Atlas-guided generation of pseudo-CT images for MRI-only and hybrid PET–MRI-guided radiotherapy treatment planning | Physics in medicine and biology | 2016 | 546 | 1 | |||
| Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis | European urology | 2016 | 557 | 0 | |||
| Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis | Cancer medicine | 2016 | 582 | 251 | |||
| Moderate Hypofractionated Protracted Radiation Therapy and Dose Escalation for Prostate Cancer: Do Dose and Overall Treatment Time Matter? | International journal of radiation oncology, biology, physics | 2016 | 542 | 580 | |||
| Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences | Clinical oncology | 2016 | 491 | 0 | |||
| Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance | International journal of radiation oncology, biology, physics | 2016 | 534 | 727 | |||
| Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging | Frontiers in oncology | 2016 | 600 | 215 | |||
| Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literature | Cancer treatment reviews | 2016 | 520 | 0 | |||
| Impact of hydrogel spacer injections on interfraction prostate motion during prostate cancer radiotherapy | Acta oncologica | 2016 | 563 | 1 | |||
| Automatic segmentation of breast in prone position: Correlation of similarity indexes and breast pendulousness with dose/volume parameters | Radiotherapy and oncology | 2016 | 513 | 3 | |||
| PET/MR in Breast Cancer | Seminars in nuclear medicine | 2015 | 618 | 0 | |||
| Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients | Nuclear-Medizin | 2015 | 620 | 0 | |||
| Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer: Zelefsky J.M. et al , Urol 2014; 192: 868-874 | The Journal of urology | 2015 | 572 | 0 | |||
| Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial | Lancet oncology | 2015 | 734 | 1 | |||
| High-dose salvage radiation therapy for prostate cancer after relapse: in regard to D'Angelillo et al | International journal of radiation oncology, biology, physics | 2015 | 448 | 1 | |||
| Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy | Technology in cancer research & treatment | 2015 | 508 | 0 | |||
| Editorial Comment from Dr Zilli and Dr Miralbell to Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria | International journal of urology | 2015 | 580 | 0 | |||
| 11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning | The Quarterly journal of nuclear medicine and molecular imaging | 2015 | 601 | 0 | |||
| Création du Centre du cancer de la prostate des HUG | Revue médicale suisse | 2014 | 759 | 2 | |||
| First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy | European journal of nuclear medicine and molecular imaging | 2014 | 794 | 1 | |||
| Spacers entre prostate et rectum : optimisation des techniques d'irradiation du cancer de la prostate [Prostate-rectum spacers: optimization of prostate cancer irradiation] | Cancer radiothérapie | 2014 | 614 | 0 | |||
| Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome | Clinical oncology | 2014 | 582 | 1 | |||
| In vivo quality assurance of volumetric modulated arc therapy for ano-rectal cancer with thermoluminescent dosimetry and image-guidance | Radiotherapy and oncology | 2014 | 575 | 0 | |||
| Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: a systematic review | International journal of radiation oncology, biology, physics | 2014 | 644 | 2 | |||
| Planning for the future: cancer incidence projections in Switzerland up to 2019 | BMC public health | 2014 | 738 | 358 | |||
| Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study | BMC urology | 2014 | 795 | 350 | |||
| PET/CT imaging and the oligometastatic prostate cancer patient: an opportunity for a curative approach with high-dose radiotherapy? | European journal of nuclear medicine and molecular imaging | 2014 | 582 | 0 | |||
| Interaction of ω-3 polyunsaturated fatty acids with radiation therapy in two different colorectal cancer cell lines | Clinical nutrition | 2014 | 686 | 1,503 | |||
| Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial | Radiation oncology | 2014 | 599 | 289 | |||
| Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: toxicity analysis | Acta oncologica | 2014 | 636 | 0 | |||
| A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy | Radiotherapy and oncology | 2014 | 530 | 0 | |||
| A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes | International journal of radiation oncology, biology, physics | 2013 | 564 | 0 | |||
| Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy | Clinical nutrition | 2013 | 946 | 2,833 | |||
| Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases | Acta oncologica | 2013 | 594 | 0 | |||
| Cancer de la prostate et déprivation androgénique: bénéfices d'un accompagnement psychologique | Revue médicale suisse | 2013 | 692 | 454 | |||
| Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study | BMC urology | 2013 | 1,181 | 360 | |||
| Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study | International journal of radiation oncology, biology, physics | 2012 | 612 | 0 | |||
| Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma | Radiation oncology | 2012 | 695 | 316 | |||
| Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer | European journal of nuclear medicine and molecular imaging | 2012 | 539 | 1 | |||
| Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT | Radiation oncology | 2012 | 607 | 351 | |||
| The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy | Radiation oncology | 2012 | 637 | 295 | |||
| Breathing adapted radiotherapy: a 4D gating software for lung cancer | Radiation oncology | 2011 | 693 | 321 | |||
| Soin nutritionnel intégré au soin oncologique : un besoin d'optimisation | Revue médicale suisse | 2011 | 988 | 857 | |||
| Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation | European journal of haematology | 2011 | 682 | 0 | |||
| Oncology ESAB 2011 | 2011 | 685 | 10 | ||||
| The Essential Role of Radiotherapy in the Treatment of Merkel Cell Carcinoma: A Study From the Rare Cancer Network | International journal of radiation oncology, biology, physics | 2011 | 483 | 0 | |||
| Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study | International journal of radiation oncology, biology, physics | 2010 | 604 | 0 | |||
| Incidental detection of synchronous primary tumours during staging workup for prostate cancer | Schweizerische medizinische Wochenschrift | 2010 | 678 | 102 | |||
| Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors | Annals of oncology | 2010 | 628 | 1 | |||
| Boosting the tumor bed from deep-seated tumors in early-stage breast cancer: a planning study between electron, photon, and proton beams | Radiotherapy and oncology | 2010 | 604 | 0 | |||
| Hypofractionated extracranial stereotactic radiotherapy boost for gynecologic tumors: a promising alternative to high-dose rate brachytherapy | Technology in cancer research & treatment | 2010 | 608 | 0 | |||
| Unilateral radiotherapy for tonsil cancer: potential dose distribution optimization with a simple two-field intensity-modulated radiation therapy beam arrangement | Radiotherapy and oncology | 2010 | 540 | 0 | |||
| Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: acute toxicity | Technology in cancer research & treatment | 2010 | 560 | 0 | |||
| Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study | Radiotherapy and oncology | 2009 | 594 | 0 | |||
| Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients | European journal of nuclear medicine and molecular imaging | 2009 | 676 | 668 | |||
| External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004 | Schweizerische medizinische Wochenschrift | 2009 | 535 | 0 | |||
| RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study | Radiation oncology | 2009 | 675 | 662 | |||
| Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis | Cancer | 2009 | 659 | 3 | |||
| Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancy | Clinical oncology | 2009 | 637 | 1 | |||
| 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer | Radiotherapy and oncology | 2009 | 596 | 0 | |||
| Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based study | Clinical & translational oncology | 2009 | 707 | 306 | |||
| Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence | Nuclear-Medizin | 2009 | 618 | 0 | |||
| Quality of life and social integration after allogeneic hematopoietic SCT | Bone marrow transplantation | 2008 | 627 | 0 | |||
| Recent trends in prostate cancer mortality show a continuous decrease in several countries | International journal of cancer | 2008 | 627 | 4 | |||
| Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer | European journal of nuclear medicine and molecular imaging | 2008 | 640 | 0 | |||
| [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma | Radiation oncology | 2008 | 658 | 569 | |||
| Increased risk of colon cancer after external radiation therapy for prostate cancer | International journal of cancer | 2008 | 669 | 8 | |||
| Short- and long-term mortality with localized prostate cancer | Archives of internal medicine | 2007 | 624 | 1 | |||
| Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients | Bone marrow transplantation | 2005 | 182 | 0 | |||
| Rituximab with interleukin-2 after autologous bone marrow transplantation for acute lymphocytic leukemia in second remission | Medical and pediatric oncology | 2002 | 519 | 0 | |||
| Fatal myocardial aspergillosis in an immunosuppressed child | Journal of pediatric hematology/oncology | 2001 | 584 | 0 | |||
| Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Swiss Pediatric Oncology Group | Annals of oncology | 1999 | 457 | 172 | |||
| Pediatric medulloblastoma : results of the Swiss pediatric oncology group | International journal of pediatric hematology/oncology | 1999 | 495 | 0 | |||
| Combined chemoradiotherapy for invasive bladder cancer: a feasibility approach in a non selected population | Anticancer research | 1998 | 502 | 0 | |||
| Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone | Annals of oncology | 1997 | 589 | 419 |
